Literature DB >> 18709457

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.

Claudia Figueroa-Romero1, Mahdieh Sadidi, Eva L Feldman.   

Abstract

Diabetic neuropathy is the most common complication of diabetes, affecting 50% of diabetic patients. Currently, the only treatment for diabetic neuropathy is glucose control and careful foot care. In this review, we discuss the idea that excess glucose overloads the electron transport chain, leading to the production of superoxides and subsequent mitochondrial and cytosolic oxidative stress. Defects in metabolic and vascular pathways intersect with oxidative stress to produce the onset and progression of nerve injury present in diabetic neuropathy. These pathways include the production of advanced glycation end products, alterations in the sorbitol, hexosamine and protein kinase C pathways and activation of poly-ADP ribose polymerase. New bioinformatics approaches can augment current research and lead to new discoveries to understand the pathogenesis of diabetic neuropathy and to identify more effective molecular therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18709457      PMCID: PMC4239697          DOI: 10.1007/s11154-008-9104-2

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  141 in total

1.  High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A.

Authors:  Dachun Yao; Tetsuya Taguchi; Takeshi Matsumura; Richard Pestell; Diane Edelstein; Ida Giardino; Guntram Suske; Naila Rabbani; Paul J Thornalley; Vijay P Sarthy; Hans-Peter Hammes; Michael Brownlee
Journal:  J Biol Chem       Date:  2007-08-01       Impact factor: 5.157

2.  Identification of changes in gene expression in dorsal root ganglia in diabetic neuropathy: correlation with functional deficits.

Authors:  Sally Amanda Price; Leo Arnoldus Hendrikus Zeef; Leanne Wardleworth; Andrew Hayes; David Richard Tomlinson
Journal:  J Neuropathol Exp Neurol       Date:  2006-07       Impact factor: 3.685

3.  Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress.

Authors:  Aaron P Kellogg; Rodica Pop-Busui
Journal:  Antioxid Redox Signal       Date:  2005 Nov-Dec       Impact factor: 8.401

4.  Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

Authors:  Nozomu Tanji; Glen S Markowitz; Caifeng Fu; Thomas Kislinger; Akihiko Taguchi; Monika Pischetsrieder; David Stern; Ann Marie Schmidt; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2000-09       Impact factor: 10.121

5.  Nitric oxide synthase activity in mitochondria.

Authors:  P Ghafourifar; C Richter
Journal:  FEBS Lett       Date:  1997-12-01       Impact factor: 4.124

Review 6.  Advanced glycation endproducts--role in pathology of diabetic complications.

Authors:  Nessar Ahmed
Journal:  Diabetes Res Clin Pract       Date:  2005-01       Impact factor: 5.602

Review 7.  Diabetic nephropathy: mechanisms of renal disease progression.

Authors:  Yashpal S Kanwar; Jun Wada; Lin Sun; Ping Xie; Elisabeth I Wallner; Sheldon Chen; Sumant Chugh; Farhad R Danesh
Journal:  Exp Biol Med (Maywood)       Date:  2008-01

8.  Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG.

Authors:  Laura F Gumy; Edward T W Bampton; Aviva M Tolkovsky
Journal:  Mol Cell Neurosci       Date:  2007-10-18       Impact factor: 4.314

Review 9.  Redox signaling, vascular function, and hypertension.

Authors:  Moo Yeol Lee; Kathy K Griendling
Journal:  Antioxid Redox Signal       Date:  2008-06       Impact factor: 8.401

10.  Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.

Authors:  Irina G Obrosova; Fei Li; Omorodola I Abatan; Mark A Forsell; Katalin Komjáti; Pal Pacher; Csaba Szabó; Martin J Stevens
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

View more
  90 in total

1.  Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy.

Authors:  M M Jack; J M Ryals; D E Wright
Journal:  Diabetologia       Date:  2011-06-03       Impact factor: 10.122

2.  Proteomic analysis of glycated proteins from streptozotocin-induced diabetic rat kidney.

Authors:  Ashok D Chougale; Shweta P Bhat; Swapnil V Bhujbal; Mandar R Zambare; Shraddha Puntambekar; Rahul S Somani; Ramanamurthy Boppana; Ashok P Giri; Mahesh J Kulkarni
Journal:  Mol Biotechnol       Date:  2012-01       Impact factor: 2.695

3.  Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats.

Authors:  R L VanGilder; K A Kelly; M D Chua; R L Ptachcinski; Jason D Huber
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

Review 4.  Hyperlipidemia: a new therapeutic target for diabetic neuropathy.

Authors:  Andrea M Vincent; Lucy M Hinder; Rodica Pop-Busui; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2009-12       Impact factor: 3.494

5.  Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease.

Authors:  Bhumsoo Kim; Carey Backus; Sangsu Oh; Eva L Feldman
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study.

Authors:  David J Margolis; Jayanta Gupta; Stephen R Thom; Raymond R Townsend; Peter A Kanetsky; Ole Hoffstad; Maryte Papdopoulos; Michael Fischer; Jeffrey R Schelling; Nandita Mitra
Journal:  Wound Repair Regen       Date:  2012-12-10       Impact factor: 3.617

7.  Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

8.  Anti-oxidative and anti-inflammatory effects of cinnamaldehyde on protecting high glucose-induced damage in cultured dorsal root ganglion neurons of rats.

Authors:  Dan Yang; Xiao-Chun Liang; Yue Shi; Qing Sun; Di Liu; Wei Liu; Hong Zhang
Journal:  Chin J Integr Med       Date:  2015-11-17       Impact factor: 1.978

9.  The Association between Serum GGT Concentration and Diabetic Peripheral Polyneuropathy in Type 2 Diabetic Patients.

Authors:  Ho Chan Cho
Journal:  Korean Diabetes J       Date:  2010-04-30

10.  Benefit of magnesium-25 carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy.

Authors:  Asieh Hosseini; Mohammad Sharifzadeh; Seyed Mahdi Rezayat; Gholamreza Hassanzadeh; Shokoufeh Hassani; Maryam Baeeri; Vahid Shetab-Bushehri; Dmitry A Kuznetsov; Mohammad Abdollahi
Journal:  Int J Nanomedicine       Date:  2010-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.